Zoonotic Influenza A(H7N9) Evolution and Vaccine Development
|
|
- Oliver Summers
- 5 years ago
- Views:
Transcription
1 Influenza Zoonotic Influenza A(H7N9) Evolution and Vaccine Development David E. Wentworth Chief, Virology Surveillance and Diagnosis Influenza Division, NCIRD Centers for Disease Control and Prevention Atlanta, GA USA
2 Significant Increase in A(H7N9) Infections (W5) Influenza Division Wave 5 N=766 N=320 N=135 N=224 N=119 Epidemic Curve of Confirmed Avian Influenza A(H7N9) Virus Infections of Humans Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, 18 Feb Feb 2018 (N=1,567)
3 Geographic Distribution 1 st through 4 th waves Influenza Heilongjiang Mongolia Inner Mongolia Jilin 2 Russia Nepal India Xinjiang 10 Tibet Bhutan India Bangladesh Qinghai Myanmar Thailand Sichuan Yunnan Gansu Ningxia Vietnam Laos Chongqing Guizhou 3 Shaanxi Guangxi 3 Shanxi Henan 4 Hubei 2 Hunan 34 Guangdong 195 Macao Hebei 4 Shandong 9 Anhui 38 Zhejiang Jiangxi Fujian 73 Hong Kong 16 Liaoning 1 Beijing 9 Tianjin 2 Taiwan 4 Jiangsu 103 North Korea Shanghai 50 South Korea Japan Geographic Distribution of 1 st 4 th Epidemics Confirmed Avian Influenza A(H7N9) Virus Human Infections*, March 2013-September 2016, (N=795) * Infections reported to WHO
4 Geographic Distribution 5 th wave Influenza Geographic Distribution of Fifth Epidemic Confirmed Avian Influenza A(H7N9) Virus Infections of Humans, Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, October 1, 2016-September 30, 2017 (N=766) Heilongjiang Mongolia Inner Mongolia 1 Jilin 1 Russia Nepal India Xinjiang 3 Tibet 3 Bhutan India Bangladesh Qinghai Myanmar Sichuan 38 Yunnan 7 Ningxia Gansu 5 Shaanxi 7 Chongqing 9 Guizhou 18 Vietnam Guangxi 28 Shanxi 3 Henan 24 Hubei 29 Hunan 61 Macao 2 Shandong 19 Anhui 63 Jiangxi 38 Fujian 34 Guangdong 63 Hong Kong 5 Liaoning 4 Beijing 27 Zhejiang 91 Taiwan 1 Thailand Laos Human Infections of A(H7N9) with HPAI mutation reported to WHO Human Infections of A(H7N9) with HPAI mutation identified by China CDC or Taiwan CDC LPAI human infections are by Province of Reporting; HPAI human infections are by Province of Exposure Hebei 25 Tianjin 3 Jiangsu 148 North Korea Shanghai 6 South Korea Japan
5 Older Men and Bird Markets Common in All 5 waves Influenza Age - Median 57 yrs (4 93 yrs) In contrast, H5N1 is 19 yrs (5 32) Gender - Male 70% Chronic Illness - At least one underlying disease in 53% Exposure - Poultry/live bird market exposure in 90% MMWR CDC and China CDC. Sept 2017; H5 Epi Lai et al Lancet 2016; China Daily/AFP
6 Severity in Human A(H7N9) Cases Persists in Wave 5 Influenza Severe disease - death 39% - pneumonia 90% - ICU admission 70% No sustained humanto-human transmission MMWR CDC and China CDC, Sept 2017; Photo: CGTN.
7 eb-2013 ar-2013 pr-2013 ay-2013 Jul-2013 ug-2013 ct-2013 ov-2013 ec-2013 an-2014 eb-2014 ar-2014 pr-2014 ay-2014 un-2014 ov-2014 ec-2014 an-2015 eb-2015 pr-2015 ec-2015 an-2016 eb-2016 ar-2016 pr-2016 ay-2016 un-2016 Jul-2016 ct-2016 ov-2016 ec-2016 an-2017 Evolution of Influenza A(H7) HA, H7N9 in the first 5 waves 5th epidemic H7N9 viruses Amino acid differences shown are relative to A/Shanghai/2/ A/Taiwan/3/2013 H7N9 A/Shanghai/5190T/2013 H7N9 A/Taiwan/1/2013 H7N9 A/pigeon/Zhejiang/P2/2013 H7N9 A/Taiwan/T02081/2013 H7N9 A/Zhenjiang/1/2013 H7N9 R47M A/Zhejiang/HZ1/2013 H7N9 A/Zhejiang/DTID-ZJU02/2013 H7N9 N190S A/chicken/Jiangsu/S002/2013 H7N9 A/Xuzhou/1/2013 H7N9 A/Suzhou/5/2013 H7N9 A/Nanjing/6/2013 H7N9 A/Huzhou/10/2013 H7N9 A/Nanjing/7/2013 H7N9 A/Wuxi/3/2013 H7N9 A/Huzhou/1/2013 H7N9 V24G A/Zhejiang/DTID-ZJU05/2013 H7N9 A/Zhejiang/DTID-ZJU08/2013 H7N9 A/Shanghai/07/2013 H7N9 A/Changsha/1/2013 H7N9 A/Beijing/1/2013 H7N9 A/chicken/Guangdong/SD641/20 13 H7N9 A/Shanghai/2/2013 H7N9 A/Wuxi/1/2013 H7N9 A/Anhui/1/2013 H7N9 Q213P A/Zhejiang/DTID-ZJU10/2013 H7N9 A/Zhejiang/22/2013 H7N9 A/Jiangsu/98342/2014 H7N9 A/chicken/Jilin/SD020/2014 H7N2 L168I S290N zzz A/silkie chicken/jiangxi/9469/2014 R47K R303K A/Zhejiang/LS01/2014 H7N9 A125V A125T V49I I280T A/Zhejiang/1/2016 H7N9 * T36K D109E z A/duck/Wenzhou/RAQL10/2 015 H7N9 * A/chicken/Zhangzhou/8585/ 2014 E104G V177A S237N D246V A/chicken/Shanghai/PD-CN -02/2 014 A/Huai'an/083/2014 H7N9 K2R R130K Q154H A/silkie chicken/huzhou/4213/2 013 N267D A/Hong Kong/214/2017 H7N9 E104K M227I A/Hong Kong/61/2016 H7N9 * N190S E104K N282K A/Guangdong/60923/2016 H7N9 * A/Hong Kong/VB /2016 H7N9 * E104R T156N T179I E104K A/chicken/Shantou/1550/2014 L168I A/Hong Kong/ /2014 H7N9 A/chicken/Guangdong/G1381/ 2014 H7N9 R47K N267D A/Hong Kong/5581/2014 H7N9 A74T S275N A9S A/chicken/Dongguan/1100/2014 mixed A/Hong Kong/4495/2014 H7N9 V177A A/Hong Kong/ /2014 H7N9 R47K I78V V262A N282K E104K A/Duck/Guangdong/DG103/2015 H7N9 * N267D A/Environment/Guangdong/DG127/ 2015 H7N9 * M256I N37S A/Guangdong/02496/2014 H7N9 G276R A/Hong Kong/2550/2015 H7N9 * A210E A/Hong Kong/ /2015 H7N9 * A/Chicken/Guangdong/DG592/2 014 H7N9 E25V T194I S207I R47K A/Duck/Guangdong/DG527/2014 H7N9 A/Guangdong/15SF010/2015 H7N9 * I280M I108L S134P Q213P G216A M227I S237N M256I N267D A/Hong Kong/5731/2014 H7N9 V264I N267G A/Hong Kong/3263/2014 H7N9 A/Hong Kong/ /2014 H7N9 A/silkie chicken/dongguan/1264/2014 D246E A/chicken/Shenzhen/138/2 014 V49I R47K A/silkie chicken/shantou/1406/2014 A/environment/Guangzhou/XN1291 7/2014 H7N9 A/environment/Guangzhou/XN0739 0/2014 H7N9 A/Hong Kong/ /2014 H7N9 A/Guangzhou/1/2014 H7N9 R47K T122A A/Shenzhen/SP-W1/2014 A/Guangdong/1/2013 H7N9 N282S N267D A/Hong Kong/470129/2013 H7N9 A/Hong Kong/5942/2013 H7N9 A/Hong Kong/734/2014 H7N9 T122A A/chicken/Shenzhen/712/2 013 mixed V86I R130K N282S R47K A/Guangdong/03/2013 H7N9 T116K R47K L217Q A/wild pigeon/jiangsu/sd001/2013 H7N9 A/chicken/Guangzhou/1/2 013 H7N9 A/chicken/Zhejiang/C481/2013 H7N9 A/chicken/Shanghai/S1410/2013 H7N9 A/pigeon/Wuxi/ G/2013 H7N9 L217Q A/Shanghai/JS01/2013 H7N9 G119E L217Q R130K R130K A/Environment/Guangdong/43966/ 2016 H7N9 * S118N A/Hong Kong/125/2017 H7N9 R130K A/Hong Kong/4553/2016 H7N9 * A/Hubei/39269/2016 H7N9 * R130K G261E A/Beijing/39450/2016 H7N9 * R130K A/Beijing/44066/2016 H7N9 * R130K A/Hebei/38604/2016 H7N9 * R130K N282S A/Environment/Hebei/40053/2016 H7N9 * A266D R130M N267Y R130K T122I M256I A/Jiangsu/15026/2016 A/Environment/Hebei/40052/2016 A/Environment/Hebei/40049/2016 H7N9 * H7N9 * H7N9 * R130M R130K T59A A/Hong Kong/793/2016 H7N9 * A/Anhui/45322/2016 H7N9 * A/Fujian/30766/2016 H7N9 * A/Hunan/02650/2016 H7N9 * A128V/A A/Fujian/4/2016 H7N9 * R130K A/Fujian/17527/2016 H7N9 * A/Fujian/54840/2016 H7N9 * K184N A/Fujian/45970/2016 H7N9 * A/Fujian/5/2016 H7N9 * K184N/K A/Jiangsu/15027/2016 H7N9 * A/Liaoning/44068/2016 K184N/K H7N9 * A/Jiangsu/05155/2016 H7N9 * A112T M227I S127G A/Tianjin/43917/2016 H7N9 A/Hunan/04137/2016 H7N9 * A/Hunan/04135/2016 H7N9 * A/Guangdong/16SF007/2016 H7N9 * I120T A/Fujian/3/2016 H7N9 * A/Hunan/06196/2016 H7N9 R130N * A/Anhui/26835/2016 H7N9 * R130K A/Guangdong/15SF871/2015 H7N9 * A/Environment/Guangdong/15125/ 2016 H7N9 * A/Fujian/30767/2016 H7N9 * S118N R130K V264I I317V A/Fujian/8/2016 H7N9 * A/Jiangsu/60454/2016 H7N9 * S118N R130K R303K A/Jiangsu/60460/2016 H7N9 * A/Jiangsu/60456/2016 H7N9 * S118N R130K M227L A292T A/Hunan/02286/2017 H7N9 A/Zhejiang/12/2016 H7N9 * A/Hebei/46587/2016 H7N9 * I38V A112T A/duck/Jiangsu/J3619/2014 H7N9 A/Jiangsu/03753/2016 H7N9 * T59I S118N R130K A/Jiangsu/06307/2014 H7N9 P212Q/P N17D A266V A/Environment/Jiangsu/03758/2015 H7N9 * A/Jiangsu/03756/2016 H7N9 * M256I I280V S218F M227I S118N A/Zhejiang/15/2016 H7N9 * A/Jiangsu/15028/2016 H7N9 * D367Y/D V86F I258V A/Anhui/26837/2016 H7N9 * A/Anhui/26836/2016 H7N9 * A/Anhui/40094/2015 H7N9 A125V A/Beijing/40610/2015 H7N9 * A/duck/Wenzhou/YJYF24/2015 H7N9 * A/Quzhou/1/2015 H7N9 * A/Guangdong/MZ828/2015 H7N9 * A/Environment/Guangdong/15120/ 2016 H7N9 * A/Environment/Guangdong/15123/ 2016 H7N9 * A112S S118N A/Guizhou/03240/2015 H7N9 * A/Fujian/09273/2015 H7N9 * G23E K319R A/Chicken/Guangdong/SW154/20 15 H7N9 * A/Shantou/2004/2015 H7N9 A/Fujian/10/2015 H7N9 * G133E D109E P206L A/Fujian/06198/2016 H7N9 * A/Fujian/1/2016 H7N9 * A/chicken/Wenzhou/HATS I101V R130K N282S LG01/2 015 H7N9 * A/Hunan/06197/2016 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * V49I A/Environment/Hunan/10086/2016 H7N9 * A/Jiangsu/19758/2015 H7N9 * A/chicken/Anhui/A1065/2014 H7N9 A/Xinjiang/98692/2014 H7N9 R103K M256I D271I S118N E269V R130K S134P A/Xinjiang/05845/2015 H7N9 * A/duck/Anhui/A1618/2014 H7N9 L168I A/Huai'an/001/2015 H7N9 * S118N I288V A/chicken/China/028/2014 H7N9 I108L S218F I258V D289N A/Fujian/27/2015 H7N9 N37S S290R S118N A/British Columbia/1/2015 H7N9 * A/Fujian/18/2015 H7N9 * K184N G216D A/Fujian/5/2015 H7N9 A/goose/Jiangsu/J1111/2014 H7N9 A/Taiwan/2/2014 H7N9 A/Taiwan/1/2014 H7N9 R346K/R A/duck/Jiangxi/15044/2014 A/Huzhou/5/2013 H7N9 S304G A/Shanghai/PD-01/2014 P206S E269K A/Shanghai/Mix1/2014 H7N9 A/Shanghai/01/2014 H7N9 L217Q S127G R211G R47K L217P S281N L57R I38F L57R R252K S118N A/Jiangsu/60466/2016 H7N9 * A/Zhejiang/6/2016 H7N9 * A/Jiangsu/60451/2016 H7N9 * A/Fujian/02152/2017 H7N9 L217I A/Anhui/60936/2016 H7N9 * I120T A/Zhejiang/13/2016 H7N9 * A/Hunan/02285/2017 H7N9 A/Jiangsu/60459/2016 H7N9 * A/Jiangsu/60457/2016 H7N9 * V214F A/Jiangsu/60458/2016 H7N9 * A/Zhejiang/11/2016 H7N9 * A/Zhejiang/14/2016 H7N9 A/Jiangsu/60447/2016 H7N9 * A/Zhejiang/16/2016 H7N9 * S127N/S A/Zhejiang/10/2016 H7N9 * A/Jiangsu/60450/2016 H7N9 * P208T A/Zhejiang/9/2016 H7N9 * A/Hong Kong/VB /2016 H7N9 * A/Anhui/60931/2016 H7N9 * A/Anhui/60932/2016 H7N9 * A/Anhui/60933/2016 H7N9 * A/Anhui/60935/2016 H7N9 * A/Anhui/60934/2016 H7N9 * A/Anhui/60926/2016 H7N9 * V170I T126A/T V262A D271N R298K S281N/S G261R/G D271G Yangtze River Delta lineage Pearl River Delta lineage
8 A(H7N9) 5 th wave hemagglutinin changes compared to A/Shanghai/2/2013 (candidate vaccine virus) Pearl River Delta lineage Yangtze River Delta lineage S118N A125V M227I A112T R130K M227I E104K L168I L168I N267D E378A D340N N282K 180 rotation 180 rotation Not visible V425I S485R Site A - green Site B - brownish Site C - dark blue Site D - cyan Site E - yellow CHO orange HA2 changes in red
9 H7N9: Treatment Implications Influenza Division Antiviral Susceptibility Observing genetic markers of reduced susceptibility ~ 9-10% available NA gene segments Viruses typically recovered from patients treated with antivirals Antiviral Treatment China CDC had recommended early treatment with oseltamivir based on clinical presentation An H7N9 bird flu patient being treated in a hospital in Hubei province Photo: STAT News
10 Status of influenza A(H7N9) candidate vaccine viruses (CVV): March 2017 Vaccine Viruses CDC and other WHO CCs developed GLP candidate vaccine virus (CVV) using reverse genetics in 2013 A/Shanghai/2/2013 RG32A used for vaccine stockpile and clinical trials Candidate vaccine virus Type Institution Available A/Anhui/1/2013 (H7N9) IDCDC-RG33A Reverse Genetics CDC Yes A/Anhui/1/2013 (H7N9) NIBRG-268 Reverse Genetics NIBSC Yes A/Anhui/1/2013 (H7N9) NIIDRG-10.1 Reverse Genetics NIID Yes A/Anhui/1/2013 (H7N9) SJ005 Reverse Genetics SJCRH Yes A/Shanghai/2/2013 (H7N9) NIBRG-267 Reverse Genetics NIBSC Yes A/Shanghai/2/2013 (H7N9) CBER-RG4A Reverse Genetics FDA Yes A/Shanghai/2/2013 (H7N9) IDCDC-RG32A Reverse Genetics CDC Yes A/Shanghai/2/2013 (H7N9) IDCDC-RG32A.3 Reverse Genetics CDC Yes
11 Analysis of Human Viruses Available March 2017 Phylogenetics of HA vrna Genetic diversity Pearl RD antigenically similar Well-inhibited by antisera to existing CVVs Yangtze RD antigenically distinct Reduced cross-reactivity with sera to existing CVV fold reduced Emergence of HPAI viruses - genetically and antigenically distinct WHO VCM Meeting Confirmed significant antigenic changes in Yangtze RD viruses - China CDC - Hong Kong University CVVs Available A/Fujian/02152/ A/Jiangsu/06463/ A/Jiangsu/06454/2017 A/Anhui/60936/2016 A/Jiangsu/60466/2016 A/Jiangsu/15027/2016 A/Hunan/04137/2016 A/Jiangsu/15026/2016 A/chicken/Fujian/11089/2016 A/Hunan/02650/2016 A/silkie chicken/shantou/9473/2016 A/Anhui/60933/2016 A/Liaoning/44068/2016 A/Tianjin/43917/2016 A/Hubei/39269/2016 A/chicken/Fujian/11766/2016 A/Hong Kong/4553/2016 A/Hong Kong/125/2017 A/Fujian/30767/2016 A/Fujian/45970/2016 A/Fujian/54840/ A/Beijing/44066/2016 A/Hebei/38604/2016 A/Anhui/45322/2016 A/Jiangsu/60460/2016 A/Hunan/06196/2016 A/Jiangsu/18828/2014 A/Jiangsu/03753/ A/Hunan/06948/2017 A/Hebei/46586/2016 A/Jiangsu/15028/2016 A/chicken/Wenzhou/WZTSLG02/2015 A/Taiwan/1/2017 A/Guangdong/17SF003/ A/Guangdong/17SF006/2017 A/Environment/Guangdong/C / A/chicken/Jiangxi/14879/2015 A/Hunan/02287/2017 A/chicken/Guangzhou/4954/2016 A/Fujian/1/ A/Xinjiang/05916/ A/Fujian/18/ A/British_Columbia/1/2015 A/Taiwan/2/2014 A/Environment/Jiangsu/03137/2013 A/chicken/Jiangxi/18482/2014 A/Taiwan/1/2014 A/chicken/Wuxi/SC4315/2015 A/chicken/Guangzhou/1083/2016 A/Guangdong/60923/ A/Hong Kong/VB /2016 A/Guangdong/60061/ A/Hong Kong/VB / A/Hong Kong/214/ A/Guangdong/60060/ A/Guangdong/17SF004/2017 A/Hong Kong/ /2015 A/Shenzhen/SP195/2015 A/Guangdong/0012/2014 A/chicken/GD/874/2014 A/Guangdong-Guangzhou/XN08763/2014 A/Guangzhou/1/2014 A/Guangdong/SP38/2014 A/Hong Kong/5942/2013 A/Anhui/02/2013 A/chicken/Wenzhou/201/2014 A/Shandong/01/2014 A/Zhejiang/1/ A/Zhejiang/17/2014_W A/chicken/Shaoxing/5201/2013 A/Huaian/065/2014 A/ZJ/22/ A/Fujian/15/2014 A/Jiangsu/09387/2014 A/Shanghai/14/2013 A/Anhui/1/2013 A/Beijing/01-A/2013 A/Shanghai/2/2013 A/ZJ/DTID-ZJU05/2013 A/shanghai/05/2013 A/Shanghai/1/2013 HPAI Pearl River Delta Yangtze River Delta CDC and WHO, Feb 2017 VCM. Human viruses are in bold font. The available CVVs are in red. The proposed CVVs are indicated by a red dot.
12 IRAT Impact & Emergence Average Risk Scores Influenza Division Impact Risk H5N6 [A/Yunnan/../2015] H7N9 [A/Hong Kong/125/2017] H7N9 [A/Shanghai/../2013] H5N1 clade 1 [A/VN/../2004] 5 H5N8 [gyrfalcon/../2014] 4 H5N1 [Am. g-w teal/../2014] H5N2 [N. pintail/../2014] 3 2 H1N1 [A/duck/NY/96] 1 = no human cases = human cases Feb 2017 Emergence Risk
13 New A(H7N9) CVVs Recommended, WHO VCM March 2017 Influenza Division From WHO s Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in humans vaccines report, dated March 2, 2017.
14 CVV Development and Safety Testing Influenza Division Genetic Engineering Illustration by Jennifer Oosthuizen
15 H7N9 CVV Generation Influenza Division A/HK/125/2017 (H7N9) LPAI - Selected at February, 2017 WHO VCM Rescue and analysis - Good Laboratory Practice rescue and amplification - Sequence analysis of the HA gene low pathogenic influenza cleavage site - Genetic stability of the HA gene upon multiple passaging (10 passages) - Chicken embryo lethality - Pathogenicity analysis in ferrets
16 IDCDC-RG56B CVV Passed 2-way Antigenic Test IDCDC-RG56B HI reactivity patterns consistent with wild-type virus A/Hong Kong/125/2017 Antisera REFERENCE ANTIGENS Clade ML/NL HK/ 125 RG56B IDCDC-RG1 (Mallard/Netherlands/12/2000-like) A/Hong Kong/125/2017 YRD IDCDC-RG56B YRD TEST ANTIGENS A/Hong Kong/4553/2016 (LP) YRD A/Hong Kong/61/2016 (LP) PRD A/Hong Kong/214/2017 (LP) PRD A/Guangdong/17SF003/2016 (HP) YRD A/Taiwan/1/2017 (HP) YRD
17 A(H7N9) CVVs May, 2017
18 Engineering Additional Constructs and CVVs Influenza Division A/Hong Kong/125/2017 A/HK/125/2017 CVVs Receptor Binding Pocket C AS-B AS-D AS-A L217Q K130R T112P 180-helix 140-loop AS-C V/G177 H174 Y186 W142 K164E AS-E P/T212 Q/L217 Y loop 210-loop S/A128 CHO 1. L217Q->Yield and HPAI
19 Influenza Division Engineering Additional Constructs and CVVs A/Hong Kong/125/2017 A/HK/125/2017 CVVs A/Guangdong/16SF003/2016 AS-B AS-A K130R K130R AS-D L217Q T112P L217Q T112P R163K AS-C K164E G261R K164E AS-E I38T CHO Fusion peptide has polybasic insertion (RKRTA) Not visible E389K I317V V425I 1. L217Q->Yield and HPAI 2. HPAI-like 4 substitutions
20 mg HA/100 eggs Influenza Division HA Yield of A(H7N9) CVVs and Antigenic Testing 7 6 IDMS SDS-PAGE Low Pathogenic YRD HPAI YRD
21 mg HA/100 eggs Influenza Division HA Yield of A(H7N9) CVVs and Antigenic Testing IDMS Low Pathogenic YRD HPAI YRD SDS-PAGE Pass Fail Fail Fail Pass
22 A(H7N9) HPAI CVV November, 2017
23 Antigenic characterization of RG viruses (RG56B-derived) containing HA1 mutations identified in 5th wave viruses Influenza Division YRD lineage T112A I227M T112A V125A S134P I227M V49I I101V T112A N282S I227M T112A A292T S127G A/duck/Jiangsu/J3619/2014 H7N9 A/Jiangsu/03753/2016 H7N9 * A/Jiangsu/06307/2014 H7N9 A/Hong Kong/VB /2016 H7N9 * A/Jiangsu/15027/2016 H7N9 * D109E V262A A/Tianjin/43917/2016 H7N9 * A/Jiangsu/05155/2016 H7N9 * S165N A/Liaoning/44068/2016 H7N9 * A/Suzhou/78/2016 H7N9 * A/Suzhou/73/2016 H7N9 * A/Suzhou/92/2017 H7N9 * R303K I120T A/Jiangsu/60460/2016 H7N9 * A/Suzhou/60/2016 H7N9 * A/Suzhou/84/2016 H7N9 * A/Jiangsu/60454/2016 H7N9 * A/Suzhou/54/2016 H7N9 * A/Suzhou/56/2016 H7N9 * A/Jiangsu/60456/2016 H7N9 * A/Suzhou/80/2016 H7N9 A/Suzhou/67/2016 H7N9 * A/Environment/Guangdong/43966/2016 H7N9 * V264I A/Fujian/30767/2016 H7N9 * A/Fujian/8/2016 H7N9 * A/Fujian/4/2016 H7N9 * A/Fujian/02151/2017 H7N9 * A/Fujian/11/2017 H7N9 * A/Fujian/14/2017 H7N9 * A/Fujian/56600/2016 H7N9 * A/Fujian/54840/2016 H7N9 * A/Fujian/17527/2016 H7N9 * A/Fujian/45970/2016 H7N9 * A/Fujian/5/2016 H7N9 * H274Y A/Anhui/13425/2017 H7N9 * D85E A/Anhui/13424/2017 H7N9 * A/Anhui/13444/2017 H7N9 * A/Anhui/13428/2017 H7N9 * A/Anhui/13427/2017 H7N9 A/Anhui/13426/2017 H7N9 * A/Anhui/13434/2017 H7N9 * A/Anhui/60925/2016 H7N9 * A/Anhui/60926/2016 H7N9 A/Anhui/13436/2016 H7N9 * A/Anhui/60932/2016 H7N9 * A/Henan/11159/2017 H7N9 * R47L A/Henan/13705/2017 H7N9 * V262A A/Henan/13706/2017 H7N9 A/Henan/11157/2017 H7N9 * A/Anhui/60935/2016 H7N9 * A/Anhui/60934/2016 H7N9 * A/Anhui/60929/2016 H7N9 A/Anhui/13442/2017 H7N9 * A/Anhui/60933/2016 H7N9 * A/Anhui/60927/2016 H7N9 * A/Anhui/13431/2017 H7N9 * A/Anhui/13441/2017 H7N9 * A/Anhui/60928/2016 H7N9 A/Anhui/13421/2017 H7N9 * A/Anhui/60931/2016 H7N9 D271N A/Anhui/13439/2017 H7N9 * A/Anhui/13433/2017 H7N9 * A/Anhui/13432/2017 H7N9 A/Guangdong/16SF007/2016 H7N9 * A/Hunan/04137/2016 H7N9 * A/Fujian/30766/2016 H7N9 * A/Hunan/02650/2016 H7N9 * A/Hubei/39269/2016 H7N9 T122I M256I A/Jiangsu/15026/2016 H7N9 * A/Hong Kong/793/2016 H7N9 * A266D A/Environment/Hebei/40053/2016 H7N9 * G261E A/Hebei/38604/2016 H7N9 * A/Beijing/39450/2016 H7N9 * A/Fujian/3/2016 A/Anhui/45322/2016 H7N9 * H7N9 * A/Hong Kong/4553/2016 H7N9 * A/Hong Kong/125/2017 H7N9 * A/Guangdong/15SF871/2015 H7N9 * A/Environment/Guangdong/15125/2016 H7N9 * A/Guangxi/6/2017 H7N9 * A/Hebei/46587/2016 H7N9 * A/Hong Kong/VB /2017 H7N9 * A/Fujian/17/2017 H7N9 * I227L K184N A/Fujian/13558/2017 H7N9 * A/Zhejiang/5/2017 A/Zhejiang/18/2016 H7N9 H7N9 * VPT17-V12.4 * A/Xinjiang/98692/2014 H7N9 A/Xinjiang/05845/2015 H7N9 * A/Henan/11158/2017 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * A/Hunan/02287/2017 H7N9 * A/Hunan/06197/2016 H7N9 * P208T A/Zhejiang/9/2016 H7N9 * A/Suzhou/88/2016 H7N9 * A/Jiangsu/60450/2016 H7N9 * A/Jiangsu/60461/2016 H7N9 * A151T Q202K A/Jiangsu/60465/2016 H7N9 * A/Suzhou/65/2016 H7N9 * A/Jiangsu/60462/2016 H7N9 * A/Zhejiang/4/2017 H7N9 * A/Hunan/00001/2016 H7N9 * V214F A/Jiangsu/60457/2016 H7N9 * A/Suzhou/57/2016 H7N9 * A/Changsha/41/2017 H7N9 * A/Chongqing/1/2017 H7N9 VPT17-V9.4 T156N A/Chongqing/2/2017 H7N9 * A/environment/ChongqingHC/2-20/2017 H7N9 * A/Guangxi/12219/2017 H7N9 * A/Guangxi/12218/2017 H7N9 * A/Suzhou/95/2017 H7N9 * A/Suzhou/96/2017 H7N9 * A/Jiangsu/60447/2016 H7N9 * A/Fujian/02152/2017 H7N9 * A/Zhejiang/14/2016 H7N9 * I120T A/Anhui/60936/2016 H7N9 * A/Zhejiang/8/2016 H7N9 * A/Zhejiang/11/2016 H7N9 * A/Zhejiang/13/2016 H7N9 * A/Jiangsu/60458/2016 H7N9 * A/Suzhou/58/2016 H7N9 * A/Suzhou/87/2016 H7N9 * A/Hubei/11951/2017 H7N9 * A/Hubei/11944/2017 H7N9 * A/Henan/11156/2017 H7N9 * A/Jiangsu/60459/2016 H7N9 * A/Suzhou/59/2016 A/Jiangsu/11581/2017 H7N9 * H7N9 * A/Zhejiang/17/2016 H7N9 * A/Anhui/60924/2016 H7N9 * A/Zhejiang/2/2017 H7N9 * A/Hunan/02285/2017 H7N9 * A/Jiangsu/11554/2017 H7N9 * A/Jiangsu/11553/2017 H7N9 * A/Zhejiang/1/2017 H7N9 * A/Hubei/11950/2017 H7N9 * A/Suzhou/74/2016 H7N9 * A/Jiangsu/11556/2017 H7N9 * A/Jiangsu/11557/2017 H7N9 * A/Jiangsu/11555/2017 H7N9 * A/Suzhou/91/2017 H7N9 * A/Jiangsu/11589/2017 H7N9 * A/Suzhou/86/2016 H7N9 * A/Zhejiang/16/2016 H7N9 * A/Jiangsu/11587/2017 H7N9 * A/Jiangsu/11586/2017 H7N9 A/Jiangsu/11590/2017 H7N9 * A/Jiangsu/11588/2017 H7N9 * A/Liaoning/13454/2017 H7N9 * A/Suzhou/90/2017 H7N9 * A/Suzhou/93/2017 H7N9 A/Jiangsu/11583/2017 H7N9 * A/Jiangsu/11585/2017 H7N9 A/Zhejiang/7/2016 A/Zhejiang/10/2016 H7N9 H7N9 * * A/Jiangsu/60452/2016 H7N9 * A/Suzhou/51/2016 H7N9 * A/Jiangsu/60451/2016 H7N9 * A/Zhejiang/6/2016 H7N9 * A/Jiangsu/60466/2016 H7N9 * A/Suzhou/79/2016 H7N9 * A/Jiangsu/60467/2016 H7N9 * A/Jiangsu/60463/2016 H7N9 A/Suzhou/63/2016 H7N9 * V93M A/Suzhou/467/2016 H7N9 * A/Zhejiang/3/2017 H7N9 A/Zhejiang/19/2016 H7N9 * A/Changsha/58/2017 H7N9 * A/Changsha/44/2017 H7N9 A/Fujian/12/2017 H7N9 * A/Fujian/8/2017 H7N9 * A/Yunnan/13501/2017 H7N9 * A/Hunan/02286/2017 H7N9 * A/Jiangxi/10683/2017 H7N9 * A/Zhejiang/12/2016 H7N9 * A/Yunnan/13500/2017 H7N9 * A/Zhejiang/6/2017 H7N9 * A/Zhejiang/20/2016 H7N9 * A/Anhui/13446/2017 H7N9 * A/Anhui/13447/2017 H7N9 * A/Anhui/13449/2017 H7N9 * A/Anhui/13423/2017 VPT17-V8.4 A/Henan/14905/2017 H7N9 * A/Henan/15337/2017 H7N9 * A/Changsha/26/2017 H7N9 * H A/Guangdong/17SF064/2017 H7N9 * HPAI and PRD lineage T112A V125A S134P I227M A/Guangzhou/1/2014 H7N9 A/Hong Kong/5942/2013 H7N9 V125A I168L I227M A/Hong Kong/734/2014 H7N9 A/Guangdong/03/2013 H7N9 R47K A/Shenzhen/SP-W1/2014 T112A N118S V125A T122A R47K K130R A/Guangdong/1/2013 H7N9 K130R I168L I227M A/Shanghai/5190T/2013 H7N9 A/Taiwan/1/2013 H7N9 A/pigeon/Zhejiang/P2/2013 H7N9 A/Taiwan/T02081/2013 H7N9 V125A I168L Q213P A/Zhejiang/DTID-ZJU10/2013 H7N9 A/Zhejiang/22/2013 H7N9 T112A N118S K130R I227M V49I I280T V125A I168L A/chicken/Zhangzhou/8585/2014 A/chicken/Shanghai/PD-CN-02/2014 R47K R303K A/Jiangsu/98342/2014 H7N9 A/silkie chicken/jiangxi/9469/2014 A/Zhejiang/LS01/2014 H7N9 T112A N118S V125A I168L A/chicken/Jilin/SD020/2014 H7N2 K130R I168L I227M A/Shanghai/Mix1/2014 H7N9 A/Shanghai/01/2014 H7N9 T112A N118S V125A A/Taiwan/3/2013 H7N9 A/Shanghai/07/2013 H7N9 K130R I168L I227M A/Changsha/1/2013 H7N9 A/Beijing/1/2013 H7N9 T112A N118S V125A A/Anhui/1/2013 H7N9 K130R I168L I227M R47M A/Zhenjiang/1/2013 H7N9 A/chicken/Jiangsu/S002/2013 H7N9 N190S A/Xuzhou/1/2013 H7N9 A/Suzhou/5/2013 H7N9 T112A N118S V125A A/Nanjing/6/2013 H7N9 K130R I168L I227M A/chicken/Guangdong/SD641/2013 H7N9 A/Shanghai/2/2013 H7N9 A/Wuxi/1/2013 H7N9 A/pigeon/Wuxi/ G/2013 H7N9 A/Shanghai/JS01/2013 H7N9 V177G A/Shanghai/1/2013 H7N9 V177G Yangtze River delta A/Xinjiang/98692/2014 H7N9 A/Xinjiang/05845/2015 H7N9 * V49I I101V T112A N282S A/Henan/11158/2017 H7N9 * A/Environment/Hunan/10125/2015 H7N9 * A/Hunan/02287/2017 H7N9 * I227M A/Hunan/06197/2016 H7N9 * H A/Guangdong/17SF064/2017 H7N9 * H A/Environment/Guangzhou/K4072/2016 H7 * H A/Environment/Guangdong/KGZ4048/2016 H7 * P112S F115L HPAI H A/Environment/Guangdong/KGZ4068/2016 VPT17-V15.4 H A/Environment/Guangdong/KGZ4075/2016 H7 * H A/Environment/Guangdong/C /2016 H7 * H A/Environment/Guangdong/C /2016 H7 * K163R R261G R320G H A/Environment/Guangdong/C /2016 H7 * H A/Environment/Guangdong/C /2016 H7N9 * R22K K163R I169V R261G H A/Guangdong/17SF037/2017 H7N9 * A/Guangdong/17SF059/2017 H7N9 H A/Guangdong/17SF033/2017 H7N9 * H A/Guangxi/7/2017 H7N9 * H A/Guangxi/1/2017 H7N9 * D148N A150T S203F H A/Guangxi/4/2017 H7N9 * Q217L H A/Taiwan/1/2017 H7N9 * H A/Guangdong/8H324/2017 H7N9 * H A/Guangdong/17SF003/2016 VPT17-V13.4 H A/Guangdong/17SF032/2017 H7N9 * K130R H A/Guangdong/17SF006/2017 H7N9 * VPT17-V14.4 H A/Guangdong/17SF039/2017 H7N9 * K163R R261G H A/Guangdong/17SF062/2017 H7N9 * V205I A/Environment/Guangdong/15120/2016 H7N9 * T112A A/Fujian/1/2016 H7N9 * A/Jiangsu/19758/2015 H7N9 * A/chicken/Wenzhou/HATSLG01/2015 H7N9 * A/Shantou/2004/2015 H7N9 I227M A/Guizhou/03240/2015 H7N9 * A/Guangdong/MZ828/2015 H7N9 * A/Chicken/Guangdong/SW154/2015 H7N9 * T112A A/Fujian/10/2015 H7N9 * N17D A266V A/Jiangsu/03756/2016 H7N9 * A/Zhejiang/15/2016 H7N9 * I227M V86F A/Jiangsu/11550/2017 VPT17-V11.4 A/Jiangsu/15028/2016 H7N9 * A/Anhui/26836/2016 H7N9 * T112A K130R I258V I227M A/Anhui/40094/2015 H7N9 A/Beijing/40610/2015 H7N9 * T112A V125A K130R I227M I288V A/duck/Wenzhou/YJYF24/2015 H7N9 * A/Quzhou/1/2015 H7N9 * A/Huai'an/001/2015 H7N9 * A/chicken/China/028/2014 H7N9 V125A N37S K130R S290R A/British Columbia/1/2015 H7N9 * A/Fujian/5/2015 H7N9 A/Taiwan/2/2014 H7N9 A/Taiwan/1/2014 H7N9 T112A N118S I227M A/duck/Jiangxi/15044/2014 K130R A/Guangxi/2/2017 H7N9 * E104K I227M V125A A/Changsha/70/2017 H7N9 * A/Hong Kong/214/2017 H7N9 * N267D A/Guangdong/60060/2016 H7N9 * A/Hong Kong/61/2016 H7N9 * A/Guangdong/60061/2016 H7N9 * V125A A/Guangdong/60923/2016 H7N9 * VPT17-V10.7 K130R N190S A/Hong Kong/VB /2016 H7N9 * A/Guangdong/15SF010/2015 H7N9 * A/Hong Kong/ /2014 H7N9 V177A N267D A/Duck/Guangdong/DG103/2015 H7N9 * M256I A/Environment/Guangdong/DG127/2015 H7N9 * E104K V125A A/Hong Kong/ /2015 H7N9 * G276R A/Hong Kong/2550/2015 H7N9 * A/Guangdong/02496/2014 H7N9 I227M A/chicken/Shantou/1550/2014 A/Hong Kong/ /2014 H7N9 A/Hong Kong/5731/2014 H7N9 T112A A/chicken/Guangdong/G1381/2014 H7N9 N118S R47K A/Hong Kong/5581/2014 H7N9 N267D A/Hong Kong/4495/2014 H7N9 A/Hong Kong/3263/2014 H7N9 A/Hong Kong/ /2014 H7N9 R47K K130R A/Hong Kong/ /2014 H7N9 A/Zhejiang/1/2016 H7N9 * A/duck/Wenzhou/RAQL10/2015 H7N9 * H A/Guangxi/5/2017 H7N9 * A/Guangxi/3/2017 H7N9 H A/chicken/Heinan/ZZ01/2017 H7N9 * Pearl River delta 0.005
24 Antigenic Diversity of A(H7N9) viruses produced by reverse genetics and derived from the RG56B (YRD) virus Boosted Boosted REFERENCE ANTIGENS Mutations ML/NL/12 RG 1 RG 56B RG56N 1 A/mld/Neth/12/ IDCDC-RG56B A/Hong Kong/125/2017 x PR IDCDC-RG56N^ T112P, K130R, K164E, L217Q VPT17-V13.4 * I38T, T112P, K130R, R163K, K164E, L217Q, G261R TEST ANTIGENS 5 VPT17-V10.7* E104R, T112A, N118S, V125A, K130R, T156N, T179I, N190S, N267D VPT17-V8.4* D109E, S127G, N146S, V262A VPT17-V9.4* T156N, V214I, G216D VPT17-V11.4* N17D, T59I, V86F, T112A, K130R, I227M, I258V, A266V VPT17-V12.4* T112A, K184N, I227L, A292T VPT17-V14.4* I38T, T112P, K130R, K164E, L217Q VPT17-V15.4* I38T, T112S, F115L, K130R, K164E, L217Q GD/ 17SF003 ^RG56N is a reverse genetics generated virus derived from RG56B with HA1 mutations that are conserved in HPAI A(H7N9) viruses *VPT17 antigens are reverse genetics generated viruses derived from RG56B with HA1 mutations identified in wt 5th wave viruses.
25 Clinical Trials Using IDCDC-RG56B Started: February, 2018 Influenza
26 Status of A(H7N9) CVVs March, 2018 Influenza Candidate vaccine virus Reactivity Institute Status IDCDC-RG56B Cross-reactive with YRD and PRD; (A/Hong Kong/125/2017-like) Does not cross-react with HPAI viruses CDC Available CNIC-HN02650 Cross-reactive with YRD and PRD; (A/Hunan/02650/2016-like) Does not cross-react with HPAI viruses China CDC Available IDCDC-RG56N Cross-reactive with LPAI and HPAI 5 th and (A/Guangdong/17SF003/2016-like) 6 th wave viruses tested CDC Available CNIC-GD003 Cross-reactive with LPAI and HPAI 5 th and (A/Guangdong/17SF003/2016-like) 6 th wave viruses tested China CDC Pending NIBRG-375 Cross-reactive with LPAI and HPAI 5 th (A/Guangdong/17SF003/2016-like) wave viruses tested NIBSC Pending CBER-RG7C Cross-reactive with LPAI and HPAI 5 th (A/Guangdong/17SF003/2016-like) wave viruses tested FDA/CBER Pending
27 A(H7N9) Summary of A(H7N9) 5th Wave 2016/2017 wave 5 epidemic -> dramatic increase in zoonosis ~ half of total cases (i.e., 766 of 1,567) Geographic dissemination Severe disease (38-40% CFR) Genetic drift of the HA viral RNA segment Pearl river delta viruses Well-inhibited by antisera to existing CVVs Yangtze River Delta HA group Predominant viruses in W5 Emergence of HPAI viruses Antigenically distinct Reduced cross-reactivity with sera to existing CVVs WHO VCM MAR, > New CVVs for low pathogenic and high pathogenic New CVVs engineered by reverse genetics (antigenicity and yield) IDCDC-RG56B (LP), antisera inhibits diverse LP viruses Clinical trial starting IDCDC-RG56N (HP), antisera broadly cross-reactive Others against HP becoming available
28 Acknowledgments Virology, Surveillance and Diagnosis Branch David Wentworth Vivien Dugan Larisa Gubareva Becky Garten Steve Lindstrom Xu Xiyan John Barnes Sam Shephard Zoonotic Virus Team, Todd Davis Yunho Jang Atanaska Marinova-Petkova Sharmi Thor Han Di Natosha Zanders Patrick Yang Joyce Jones Erin Hodges Vaccine Preparedness Team, Vivien Dugan (acting TL) Guaniri Mateu-Petit Pavani Bondugula Jaber Hossain Adam Johnson Xudong Lin Callie Ridenour Li Wang Terianne Wong International Research and Epidemiology Team, EPB Eduardo Azziz-Baumgartner James Kile Danielle Iuliano Katherine Roguski National Veterinary Services Laboratory, USDA Mia Torchetti Nicole Hines Influenza Division, OD Dan Jernigan Jackie Katz James Stevens Sue Trock Alicia Fry Director, Influenza Program U.S. CDC-China Office Carolyn Greene China CDC Shu Yuelong Dayan Wang Taiwan CDC Ji-Rong Yang Centre for Health Protection, Hong Kong Janice Lo University of Hong Kong Yi Guan Tommy Lam Zhu Hua Chen
29 Extra
30 Mar 16, 2018 Geographic Distribution Geographic Distribution of Sixth Epidemic Confirmed Avian Influenza A(H7N9) Virus Infections of Humans, Reported by WHO or in Chinese Provincial or Hong Kong CHP Press Releases, October 1, Feb 2018 (N=3)* Mongolia Inner Mongolia Jilin Heilongjian g Russi a Nepa l India Xinjiang 1 Tibet Bhuta n Banglades h India Qinghai Sichuan Yunnan 1 Gansu Chongqing Guizhou Shaanxi Guangxi Henan Shandon g Liaonin g Myanmar Vietnam Macao Hong Kong Thailan Laos Human Infections of A(H7N9) with HPAI d mutation identified by China CDC or Taiwan CDC * LPAI human infections are by Province of Reporting; HPAI human infections are by Province of Exposure Ningxi a Shanxi Hubei Hunan Hebei Jiangxi Guangdong 1 Anhui Fujian Beijin g Tianjin Zhejian g Taiwan Jiangsu North Korea Shangha i South Korea Japa n
31 HPAI H5 outbreaks animals - Reported to OIE and/or FAO; data is from OIE and FAO open sources that are available online H5N6 Ireland It Laboratory Zoonotic Influenza March 6-12, 2018 H5NX Bulgaria (1) H5N8 Italy(1) Iraq (2) Ir I H5N6 China(1) H5N6 Japan (3) H5N2 Taiwan (1) H5NX H5N1 H5N2 H5N3 H5N5 H5N6 H5N8 H5N1 India (1) Captive Birds Domestic Poultry Wild bird
32 Laboratory Zoonotic Influenza Reported February 27- March 5, 2018 A(H5) and A(H9N2) - No influenza A(H5) or A(H9N2) viruses were isolated or characterized antigenically Newly detected HPAI H5 outbreaks in animals Country Number of Outbreaks/reports Observation Date *Reported to OIE and/or FAO; data is from OIE and FAO open sources that are available online Species Description Bulgaria (H5) 1 2 March 2018 Domestic poultry India (H5N1) 1 11 Feb 2018 Domestic poultry China (H5N6) 1 22 Feb 2018 Domestic poultry Japan (H5N6) 3 1,2,3 March 2018 Wild bird Ireland (H5N6) 1 23 Feb 2018 Wild bird Iraq (H5N8) 2 4,5 March 2018 Domestic poultry Italy (H5N8) 1 2 March 2018 Domestic poultry Taiwan (H5N2) 1 24 Feb 2018 Domestic poultry
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness February 2014 The development of representative candidate influenza
More informationHPAI. Update of H7N9 in china:the epidemiological and virological features LPAI. H7N9 avian influenza viruses (before 2013)
Update of H7N9 in china:the epidemiological and virological features Yuelong Shu WHO Collaborating Center for Reference and Research on Influenza Chinese National Influenza Center National Institute for
More informationCorporate Leadership Forum March Briefing March 11, 2015
Center for Infectious Disease Research and Policy University of Minnesota Corporate Leadership Forum March Briefing March 11, 2015 Michael T. Osterholm, PhD, MPH McKnight Presidential Endowed Chair in
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2018 The development of influenza candidate vaccine
More informationChina HPAI Situation - Update
JUNE 2012 NO.6 China HPAI Situation - Update CHINA ECTAD-CHINA HPAI Outbreak Situation Update (2010 - e 2012) HPAI Surveillance Situation Update (2010-2011) HPAI H5N1 Virus Monitoring and New Vaccine Development
More informationCurrent Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?
Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2014 The development of representative candidate influenza
More informationHO Global Influenza Program: Human-Animal Interface Team) PAI Activities FAO/OIE/WHO Tripartite Animal Health Meeting.
2007 FAO/OIE/WHO Tripartite Animal Health Meeting HO Global Influenza Program: Human-Animal Interface Team) PAI Activities 1 January 2007 iz Mumford ike Perdue ui-hong Chung Current Activities WHO Working
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2013 The development of representative candidate influenza
More informationInfluenza at the human-animal interface
Influenza at the human-animal interface Summary and assessment, 17 January to 14 February 2017 New infections 1 : Since the previous update, new human infections with influenza A(H7N9) and A(H1N1)v viruses
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2015 The development of candidate influenza vaccine
More informationPossible pandemic threat from new reassortment of influenza A(H7N9) virus in China
Rapid communications Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China Z Meng 1, R Han 2, Y Hu 1, Z Yuan 1, S Jiang 1, X Zhang 1,3, J Xu (jianqingxu2008@gmail.com) 1,3
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness September 2017 The development of candidate influenza vaccine
More informationPolio Bulletin 2014 Issue No Week 25 (as of 23 Jun 2014)
Non-polio AFP rate Cases with adequate specimens (%) HIGHLIGHTS T e c h n i c a l A d v i s o r y G r o u p m e e t i n g, Manila, 17-20 June 2014 The 23rd meeting of the Technical Advisory Group (TAG)
More informationAntigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness
4 Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness February 2018 The development of influenza candidate vaccine
More informationGlobal and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness
Global and Regional Situation of Zoonotic Influenza in Humans, and Pandemic Preparedness Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National
More informationChinese Influenza Weekly Report
Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 26, influenza activity level in mainland China was very low, only a few A(H1N1)pdm09
More informationChinese Influenza Weekly Report
National Institute for Viral Disease Control and Prevention, China CDC Chinese Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 17, influenza activity
More informationChinese Influenza Weekly Report
Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 23, influenza activity level in mainland China was very low, only a few influenza
More informationChinese Influenza Weekly Report
Chinese Influenza Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 27, influenza activity level in mainland China was very low, only a few influenza
More informationAvian Influenza A(H7N9) 13 February 2014 Surveillance Update
Avian Influenza A(H7N9) 13 February 2014 Surveillance Update Summary The WHO has reported 337 human infections including 66 deaths with onset since February 2013. There are still no signs of ongoing, efficient,
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 18/09/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening
More informationGlobal Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season
Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere 2015-16 Influenza Season Jacqueline Katz, Ph. D. Deputy Director (acting), Influenza Division
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 10/07/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 28/02/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and
More informationOFFLU AVIAN INFLUENZA REPORT
OFFLU AVIAN INFLUENZA REPORT Avian Influenza Events in Animals for the period February to September 2017 Scope In this document we present a summary of H5, H7, and H9 avian influenza events that occurred
More informationSupplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,
Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, TY93/H5N1 GFP-627K, or the TY93/H5N1 PB2(588-759) virus library. To establish our GFP- FACS screening platform, we compared
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 24/04/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with
More informationInfluenza A(H5N1) activity from 27 September 2010 to 15 February 2011
Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for the development of candidate vaccine viruses for pandemic preparedness February 2011 The development of representative
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 25/01/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and strains within
More informationMalaria Situation and Control in China
Malaria Situation and Control in China Dr Guan Yayi National Institute of Parasitic Diseases, China CDC March 16, 2010 Luang Prabang, Lao PDR Malaria in China (1952-2009) 0 50 100 150 200 250 300 1952
More informationTITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
More informationVirological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication
Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European
More informationH5N1 avian influenza: timeline
H5N1 avian influenza: timeline 28 October 2005 Previous events in Asia 1996 Highly pathogenic H5N1 virus is isolated from a farmed goose in Guangdong Province, China. 1997 Outbreaks of highly pathogenic
More informationThe A(H7N9) influenza outbreak in China
Viruses in May, Katoomba, 9 11 May 2013 The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for Reference and Research on Influenza Melbourne Influenza in the 21 st century:
More informationSupplementary Figure 1 Weight and body temperature of ferrets inoculated with
Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with
More informationAvian Influenza A(H7N9) 6 February 2014 Surveillance Update
Avian Influenza A(H7N9) 6 February 2014 Surveillance Update Summary The WHO has reported 298 human infections including 63 deaths with onset since February 2013. There are still no signs of ongoing, efficient,
More informationContribution of avian influenza data through OFFLU network
Dr Gounalan Pavade Chargé de Mission, OIE Headquarters Contribution of avian influenza data through OFFLU network Asia-Pacific Workshop on surveillance, prevention and control of zoonotic influenza Paro,
More informationAvian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences
Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments
More informationOFFLU contribution to the WHO vaccine selection meeting
OFFLU contribution to the WHO vaccine selection meeting WHO Consultation on the Composition of Influenza Vaccines for the Southern Hemisphere 0 (0- Feb 0, Geneva) Giovanni Cattoli OFFLU Annual technical
More informationPublic health relevant virological features of Influenza A(H7N9) causing human infection in China
Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 08/05/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening
More informationMiddle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update
30 August 2013 Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update Alert and Response Operations International Health Regulations, Alert and Response and Epidemic
More informationUpdate on Zoonotic Infections with Variant Influenza A Viruses in the USA
Update on Zoonotic Infections with Variant Influenza A Viruses in the USA Todd Davis Zoonotic Virus Team Virology, Surveillance and Diagnosis Branch Influenza Division CDC, Atlanta OFFLU Swine Influenza
More informationOFFLU AVIAN INFLUENZA POST VCM REPORT
OFFLU AVIAN INFLUENZA POST VCM REPORT Avian Influenza Events for the period September 2017 to February 2018 Scope In this document we present a summary of H5, H7, and H9 avian influenza events that occurred
More informationRegional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP
Regional Overview of the implementation of National Control Strategies for Avian Influenza Summary review of questionnaire OIE RRAP The OIE Questionnaire on Influenza A surveillance in animals in the Asia
More informationSupplementary Online Content
Supplementary Online Content Linderman GC, Lu J, Lu Y, et al. Association of body mass index with blood pressure among 1.7 million Chinese adults. JAMA Netw Open. 2018;1(4):e181271. doi:10.1/jamanetworkopen.2018.1271
More informationJapanese Encephalitis in Mainland China
Jpn. J. Infect. Dis., 62, 331-336, 2009 Review Japanese Encephalitis in Mainland China Wang Huanyu, Li Yixing 1, Liang Xiaofeng 1, and Liang Guodong* State Key Laboratory for Infectious Disease Control
More informationAgricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA
Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA David L. Suarez Southeast Poultry Research Laboratory, Exotic and Emerging Avian Viral Diseases Research
More informationQuantifying predictors for the spatial diffusion of avian influenza virus in China
Lu et al. BMC Evolutionary Biology (2017) 17:16 DOI 10.1186/s12862-016-0845-3 RESEARCH ARTICLE Quantifying predictors for the spatial diffusion of avian influenza virus in China Lu Lu 1, Andrew J. Leigh
More informationIMMUNITY TO INFLUENZA INFECTION. Unit 7 Paul Thomas Department of Immunology St. Jude Children s Research Hospital
IMMUNITY TO INFLUENZA INFECTION Unit 7 Paul Thomas Paul.Thomas@stjude.org Department of Immunology St. Jude Children s Research Hospital INFLUENZA A VIRUS Negative sense, segmented RNA virus Orthomyxoviridae
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 30/06/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with
More informationAvian Influenza/Newcastle Disease Virus Subcommittee
Avian Influenza/Newcastle Disease Virus Subcommittee David L. Suarez D.V.M., Ph.D. Patti Miller D.V.M., Ph.D. Claudio Afonso Ph.D. Southeast Poultry Research Laboratory United States National Poultry Research
More informationHuman infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013
Rapid communications Human infection with avian influenza A(H7N9) virus re-emerges in in winter 2013 E Chen 1,2, Y Chen 1,2, L Fu 2,3, Z Chen 1, Z Gong 1, H Mao 1, D Wang 4, M Y Ni 5, P Wu 5, Z Yu 1, T
More informationOrigins and evolutionary genomics of the novel avian-origin H7N9 influenza A virus in China: Early findings
Origins and evolutionary genomics of the novel 2013 avian-origin H7N9 influenza A virus in : Early findings Jiankui He*, Luwen Ning, Yin Tong Department of Biology, South University of Science and Technology
More informationVIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks
INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry
More informationAvian influenza viruses from the global perspective
Avian influenza viruses from the global perspective Wenqing Zhang SARI Surveillance in the Americas (SARInet) Meeting 28-30 April 2015 Cancun, Mexico Complex modern world Increasingly crowded Growth in
More informationTo test the possible source of the HBV infection outside the study family, we searched the Genbank
Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),
More informationTodd Davis Influenza Division Centers for Disease Control and Prevention Atlanta, GA USA
OFFLU influenza virus meeting 27 28 March 2017 FAO Headquarters, Rome, Italy Todd Davis Influenza Division Centers for Disease Control and Prevention Atlanta, GA USA Strains of concerns Influenza A(H3N2)v
More informationQualitative risk assessment update
February 2019 ANIMAL HEALTH RISK ANALYSIS ASSESSMENT No. 8 Chinese-origin H7N9 avian influenza spread in poultry and human exposure Qualitative risk assessment update FAO/Xavier Roche The current risk
More informationFor the control of avian influenza
OIE Regional Expert Group Meeting for the Control of Avian influenza in Asia Sapporo, 3-5 October 2017 For the control of avian influenza Hiroshi Kida Hokkaido University Research Center for Zoonosis Control
More informationGLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA
GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA Dr Gounalan Pavade OIE Regional Expert Group Meeting for the Control of Avian Influenza in Asia Sapporo, Japan 3-5 October 2017 1 Avian influenza Outbreaks
More informationAvian Influenza (AI) National & International Update
Avian Influenza (AI) National & International Update T.J. Myers, F. Hegngi, A. Rhorer, P. Klein, T. Duvernoy & M. David USDA, APHIS, Veterinary Services Delmarva Breeder, Hatchery & Grow Out Conference
More informationAntigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use in human vaccines September 2008 It is not known if the next influenza pandemic will
More informationWestern Pacific Regional Office of the World Health Organization
Western Pacific Regional Office of the World Health Organization Avian Influenza Weekly Update Number 420 (14 February 2014) http://www.wpro.who.int/emerging_diseases/avianinfluenza/en/index.html Human
More informationResearch Issues in Animal Surveillance and Pandemic Planning
Research Issues in Animal Surveillance and Pandemic Planning Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s Research Hospital SURVEILLANCE Spread of H5N1
More informationImproving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress
Improving Care for Cardiovascular Disease in China: A collaborative project of AHA and CSC (The CCC Project) Project Progress Beijing Anzhen Hospital, Capital Medical University Beijing Institute of Heart
More informationINFLUENZA-2 Avian Influenza
INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature
More informationAvian Influenza Viruses with Pandemic Potential
Avian Influenza Viruses with Pandemic Potential Takato Odagiri Director WHO Collaborating Center on Influenza, Tokyo and Influenza Virus Research Center, National Institute of Infectious Diseases, Japan
More informationInfluenza A (H7N9) Control in China
Influenza A (H7N9) Control in China Zhang Zhongqiu China Delegate to OIE DG, Veterinary Bureau, Ministry of Agriculture, the People s Republic of China 2013.05.30 Outline 1. Human cases of H7N9 2. Control
More informationReview of Avian Influenza A(H5N1) for WHO SAGE
Review of Avian Influenza A(H5N1) for WHO SAGE SAGE Geneva November 2013 Joseph Bresee, MD Epidemiology and Prevention Branch Influenza Division National Center for Immunization and Respiratory Diseases
More informationPlanning and preparation for influenza pandemics are
Use of Influenza Risk Assessment Tool for Prepandemic Preparedness Stephen A. Burke, Susan C. Trock In 2010, the Centers for Disease Control and Prevention began to develop an Influenza Risk Assessment
More informationHPAI H5(N8) in Member States in poultry, captive and wild birds
HPAI H5(N8) in Member States in poultry, captive and wild birds (01/10/2016-01/03/2017) DG Health and Food Safety 13,578,000 5,610,000 234,000 Broad migration flows of ducks across Europe 1,000,000 71,000
More informationSEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response
SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Regional Response SARS Preparedness and Response Team World Health Organization Western Pacific Regional Office Western Pacific Region of WHO Jilin Ulaanbaatar
More informationIntroduction to Avian Influenza
Introduction to Avian Influenza David L. Suarez D.V.M., Ph.D. Research Leader Exotic and Emerging Avian Viral Disease Research Unit Agricultural Research Service United States Department of Agriculture
More informationOFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome
OFFLU STEERING AND EXECUTIVE COMMITTEE MEETING 31 March 2017 FAO Headquarters, Rome Participants: Peter Daniels, Ian Brown, Billy Karesh, David Swayne, Giovanni Cattoli, Nicola Lewis, Gwenaelle Dauphin,
More informationAAHL s Regional One-Health Activities
International partnerships Disease reservoirs Unique capability AAHL s Regional One-Health Activities Dr. Kurt Zuelke Director, Health & Biosecurity and AAHL 30 October 2015 6 th Asia Pacific Workshop
More informationAvian influenza - current situation and future trends
Avian influenza - current situation and future trends Calogero Terregino OIE, FAO and National Reference Laboratory for Newcastle Disease and Avian Influenza, Istituto Zooprofilattico Sperimentale delle
More informationインフルエンザの疫学について 国 感染研インフルエンザウイルス研究センター WHOインフルエンザ協 センターセンター 切孝
インフルエンザの疫学について 国 感染研インフルエンザウイルス研究センター WHOインフルエンザ協 センターセンター 切孝 1 Influenza A Viruses All influenza A virus subtypes are detected in aquatic birds H1 - H16 N1 - N9 Aquatic birds Poultry Humans Pigs Horses
More informationUpdate on influenza monitoring and vaccine development
Update on influenza monitoring and vaccine development Annette Fox WHO Collaborating Centre for Reference and Research on Influenza at The Peter Doherty Institute for Infection and Immunity 1 Outline Why
More informationOverview of human cases of AI H5N1 since 1997
Overview of human cases of AI H5N1 since 1997 Dr Sylvie Briand WHO Global Influenza Programme 7 October 2008 1 FAO-OIE- WHO Joint Technical Consultation on AI at the Human-Animal Interface Review of the
More informationCurrent Situation on Avian Influenza and the pandemic threat
Vaccine-preventable diseases and Immunization, Communicable Diseases Surveillance and Response Current Situation on Avian Influenza and the pandemic threat IVth Joint EC/ECDC/WHO Workshop on Pandemic Influenza
More informationAI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia,
AI surveillance of domestic birds in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia, 2008-2012 Kenji Sakurai, OIE Asia-Pacific Tokyo, 13-14 December 2012 Contents
More informationOn 31 March 2013, the National Health and
Perspective Avian influenza A(H7N9) and the closure of live bird markets Manoj Murhekar, a Yuzo Arima, a Peter Horby, a Katelijn AH Vandemaele, b Sirenda Vong, c Feng Zijian, d Chin-Kei Lee, a Ailan Li
More informationPandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva
Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States
More informationIdentifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract)
PAA 2012 manuscript No. (will be inserted by the editor) Identifying the Long-Term Effect of Prenatal Famine Exposure on Female Sterility (Extended Abstract) Shige Song April 2, 2012 1 Introduction Female
More informationRecommended composition of influenza virus vaccines for use in the influenza season
Recommended composition of influenza virus vaccines for use in the 2006 2007 influenza season This recommendation relates to the composition of vaccines for the forthcoming influenza season in the northern
More informationFare clic per modificare lo stile del titolo. Regional Perspective on HPAI
Regional Perspective on HPAI Emergency Center for Transboundary Animal Diseases Inception meeting of the OIE/JTF Project for Controlling Zoonoses in Asia under One Health Concept Tokyo, Japan, 19-20, December
More informationAvian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center
Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center Definitions: Epidemic The occurrence of cases of an illness in a community or region which
More informationFlu, Avian Flu and emerging aspects (H1N1 resistance)
EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory
More informationSignificantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017
Research article Significantly elevated number of human infections with H7N9 virus in Jiangsu in eastern China, October 2016 to January 2017 Xiang Huo 1,2, Liling Chen 2,3, Xian Qi 1,2, Haodi Huang¹, Qigang
More informationReport from AI EURL on the developing situation with H5 HPAI
Report from AI EURL on the developing situation with H5 HPAI Andrew Breed and Ian Brown andrew.breed@apha.gsi.gov.uk PAFF Committee, section Animal Health and Welfare 4 th February 205, Brussels Recent
More informationSurveillance Overview
Number of Positive Specimens Percent Positive Number of Positive Specimens National Center for Immunization & Respiratory Diseases 2016-17 Surveillance Overview Lynnette Brammer, MPH Epidemiologist, Influenza
More informationPromoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases
Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases Masaya Kato, WHO Viet Nam OIE Regional Workshop on Enhancing Influenza A viruses National Surveillance
More informationInfluenza: Seasonal, Avian, and Otherwise
Influenza: Seasonal, Avian, and Otherwise Lisa Winston, MD University of California, San Francisco San Francisco General Hospital Influenza biology Antiviral medications Seasonal influenza Vaccination
More informationControl of Influenza A(H7N9) A HKU-China CDC Collaboration
Control of Influenza A(H7N9) A HKU-China CDC Collaboration Gabriel M Leung, Benjamin J Cowling, Joseph T Wu Public Health Research Centre The University of Hong Kong Li Ka Shing Faculty of Medicine October
More informationOIE tools and global overview on Avian Influenza Dr Jocelyn Mérot OIE Sub Regional Representation for North Africa Tunis, Tunisia
10 th JPC REMESA - Heraklion, Greece (16-17 March 2015) OIE tools and global overview on Avian Influenza Dr Jocelyn Mérot OIE Sub Regional Representation for North Africa Tunis, Tunisia 1 Global management
More informationApplication of Reverse Genetics to Influenza Vaccine Development
NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective
More informationHighly Pathogenic Avian Influenza Virus Research
Highly Pathogenic Avian Influenza Virus Research Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s Research Hospital Memphis, TN Influenza A Viruses 15 HA
More information